Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.
Dexcom (($DXCM)) announced an update on their ongoing clinical study. Study Overview: The COMPASS Program, officially titled ‘Continuous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback